June 19, 2018

MEDIA ADVISORY: Lt. Governor Polito Announces Inaugural Awards for MassNextGen Awards

Media Advisory: Wednesday June 20, 2018

CONTACT: Colleen Arons (HED) – colleen.arons@mass.gov 
Joe Sullivan (MLSC) – jsullivan@masslifesciences.com (781) 795-6259

CAMBRIDGE – Lt. Governor Polito will join Massachusetts Life Science Center President & CEO Travis McCready, King Street Properties and leaders from the Life Sciences sector to celebrate the inaugural awards announcements for the MassNextGen Initiative.

MassNextGen is a competitive program to support women entrepreneurs in early-stage life sciences companies. The public-private partnership between the Massachusetts Life Sciences Center and corporate sponsors Takeda and King Street Properties is a five-year, $1.1 million commitment focused on empowering women and diversity in the next generation of life sciences entrepreneurs.

A networking reception will follow the award announcements. Event hosted by King Street Properties.

Event Details:

WHAT:            Massachusetts Life Sciences Center (MLSC) Massachusetts Next Generation (MassNextGen) Initiative Inaugural Awards Announcement 

WHEN:            Wednesday, June 20, 2018    4:00 – 6:00 PM

WHERE:           King Street Properties 200 Cambridge Park Drive Cambridge, MA

WHO:              Lt. Governor Karyn Polito

Travis McCready, Massachusetts Life Sciences Center, President & CEO

Jennifer Griffin, Massachusetts Life Sciences Center, Vice President for Industry Programs and Relations

Liz Lewis, Takeda, Chief Counsel, Head Patient Advocacy Global Oncology Business Unit

Thomas Ragno, King Street Properties, Founder and Principal

Stephen Lynch, King Street Properties, Principal

About the Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) is an economic development investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world. Through public-private funding initiatives, the MLSC supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. Since its creation in 2007, the MLSC has strategically deployed over $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs, and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.